Related Experiment Video
Updated: Sep 21, 2025

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Published on: June 13, 2025
Elizabethkingia anophelis outbreak in France
B Guerpillon1, M S Fangous2, E Le Breton3
1Centre Hospitalier de Cornouaille, Service de maladies infectieuses, 14, avenue Yves Thépot, Quimper, France.
An outbreak of Elizabethkingia anophelis infections occurred in France, causing severe illness and nine deaths. This multidrug-resistant bacterium requires clinical awareness, with cotrimoxazole and ciprofloxacin recommended for treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Elizabethkingia anophelis is an emerging pathogen.
- This is the first reported outbreak in Europe.
Purpose of the Study:
- To describe the first European outbreak of Elizabethkingia anophelis infections.
- To characterize the clinical, microbiological, and epidemiological features of the outbreak.
Main Methods:
- Case definition: E. anophelis-positive microbiological sample.
- Clinical, environmental, and microbiological investigations including MALDI-TOF, PCR, and E-test.
- Phylogenetic analysis to determine transmission patterns.
Main Results:
- Twenty cases reported between September 2020 and September 2021.
- Predominantly community-acquired infections leading to nine deaths.
- Clonal origin identified, excluding nosocomial spread; no environmental source found.
- All isolates exhibited high resistance to cefotaxime, ceftazidime, and imipenem.
Conclusions:
- Elizabethkingia anophelis is a multidrug-resistant bacterium causing severe infections.
- Cotrimoxazole and ciprofloxacin demonstrated the lowest minimum inhibitory concentrations.
- These antibiotics are recommended for empirical therapy against E. anophelis.
Related Concept Videos
Steps in Outbreak Investigation
Lysogenic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
Lytic Cycle of Bacteriophages

